Assoc. Prof. Dr . Saadi Samadi | Organic Chemistry Award | Best Researcher Award

Assoc. Prof. Dr . Saadi Samadi | Organic Chemistry Award | Best Researcher Award

Assoc. Prof. Dr . Saadi Samadi , University of Kurdistan, Iran

Saadi Samadi, born on April 4, 1982, in Bijar, Kurdistan, Iran, is an esteemed Associate Professor of Organic Chemistry at the University of Kurdistan. He specializes in asymmetric synthesis, focusing on enantioselective processes and the development of chiral nanocatalysts. With a Ph.D. in Organic Chemistry from Shahid Beheshti University, his research contributions have significantly advanced the field. Samadi has published extensively in reputable journals and is recognized for his innovative approach to drug synthesis and catalysis. His dedication to education is reflected in his teaching of various organic chemistry courses at undergraduate and postgraduate levels. He actively collaborates with peers in both local and international research initiatives, striving to foster a deeper understanding of organic chemistry’s practical applications.

Professional Profile:

Scopus

Orcid

Summary of Suitability for Award:

Dr. Saadi Samadi, an Associate Professor of Organic Chemistry at the University of Kurdistan, demonstrates exceptional contributions to the field of asymmetric synthesis and chiral catalysis. With a Ph.D. focused on the synthesis of chiral ligands and their applications, he has published numerous high-impact research articles, showcasing innovative methodologies and novel catalysts. His work has implications in drug synthesis and enantioselective reactions, addressing key challenges in organic chemistry. Dr. Samadi’s dedication to research is evidenced by his continuous pursuit of sustainable and efficient catalysts, making significant advancements in both homogeneous and heterogeneous catalysis. Furthermore, his active participation in international collaborations and conferences enhances his visibility and impact in the scientific community. Dr. Samadi’s achievements align with the criteria for the “Best Researcher Awards,” reflecting his commitment to excellence in research, impactful publications, and contributions to the advancement of chemistry.

🎓Education:

Saadi Samadi obtained his Ph.D. in Organic Chemistry with a specialization in Asymmetric Synthesis from Shahid Beheshti University, Iran, from 2008 to 2013. His doctoral research focused on the synthesis of chiral oxazoline and bisoxazoline ligands, investigating their potential in asymmetric allylic oxidation reactions using heterogeneous and homogeneous phases. Prior to his Ph.D., he completed his MSc in Organic Chemistry, also at Shahid Beheshti University, where he explored the synthesis of chiral biarylbisoxazoline ligands and their applications. Samadi earned his Bachelor’s degree in Applied Chemistry from Razi University, Iran, between 2001 and 2005. His comprehensive education laid a strong foundation for his expertise in asymmetric synthesis and catalysis, enabling him to contribute significantly to the field of organic chemistry through both teaching and research.

🏢Work Experience:

Saadi Samadi has over a decade of academic experience, currently serving as an Associate Professor in the Department of Chemistry at the University of Kurdistan since 2022. He previously held the position of Assistant Professor at the same university from 2015 to 2021 and served in the Gas Conversion Department at the Iran Polymer and Petrochemical Institute from 2014 to 2015. Samadi has taught a variety of subjects across different academic levels, including Asymmetric Synthesis and Advanced Organic Chemistry at the Ph.D. level, and General Chemistry and Organic Chemistry at the Bachelor’s level. His commitment to education is complemented by his active involvement in research, where he focuses on developing innovative methodologies in asymmetric synthesis and drug synthesis. His diverse teaching and research experience reflect his dedication to advancing the field of organic chemistry and mentoring the next generation of chemists.

🏅Awards:

Saadi Samadi has received recognition for his contributions to the field of organic chemistry and education. He was honored with the “Outstanding Researcher Award” at the University of Kurdistan for his significant achievements in asymmetric synthesis and nanocatalyst development. Additionally, Samadi has been awarded various research grants to support his projects focused on enantioselective synthesis and drug development. His work has garnered accolades from both academic and industrial communities, emphasizing the impact of his research on practical applications. He has also been invited to speak at numerous international conferences, showcasing his findings and collaborating with fellow researchers. Samadi’s commitment to excellence in research and teaching has earned him a reputation as a leading figure in his field, and he continues to inspire students and peers alike through his contributions to science and education.

🔬Research Focus:

Saadi Samadi’s research focuses primarily on asymmetric synthesis, specifically enantioselective synthesis and the development of chiral nanocatalysts. His work aims to create innovative methodologies for the synthesis of chiral compounds that are crucial for pharmaceutical applications. He explores the synthesis of homogeneous and heterogeneous chiral catalysts to enhance the efficiency of asymmetric reactions. Samadi’s research includes the total synthesis of complex organic molecules and the design of new catalysts that improve reaction selectivity and yield. His investigations into drug synthesis contribute to the advancement of therapeutic agents, addressing critical challenges in medicinal chemistry. By integrating nanotechnology with organic synthesis, Samadi aims to develop more sustainable and effective catalytic systems. His ongoing projects include the application of chiral nanocatalysts in various organic transformations, significantly impacting the field of organic and medicinal chemistry.

Publication Top Notes:

  • Enhancing catalytic activity of UiO-66 through CuO nanoparticles incorporation: a study on Henry reaction and one-pot allylic C-H bond oxidation of olefins
  • Investigating the potential of rhamnolipid as an eco-friendly surfactant for environmental protection in oil spill clean-up
    • Citations: 5
  • Application of chiral Betti base-copper complexes in enantioselective allylic oxidation of olefins, computational studies of the Betti bases, and docking of the resulting chiral allylic esters
    • Citations: 2
  • Chiral Pseudohomogeneous Catalyst Based on Amphiphilic Carbon Quantum Dots for the Enantioselective Kharasch−Sosnovsky Reaction
    • Citations: 8
  • Preparation and DFT studies of chiral Cu (I)-complexes of biphenyl bisoxazolines and their application in enantioselective Kharasch–Sosnovsky reaction
    • Citations: 7

 

 

 

 

Dr. Seyed Mohammad Amini | Green Chemistry Award | Best Researcher Award

Dr. Seyed Mohammad Amini | Green Chemistry Award | Best Researcher Award

Dr. Seyed Mohammad Amini | Iran University of Medical Sciences | Iran

Seyed Mohammad Amini, Ph.D., is a dedicated scientist and Assistant Professor at the Radiation Biology Research Center, Iran University of Medical Sciences, specializing in medical nanotechnology. Born on February 1, 1986, he has over a decade of experience in research and development, particularly in biopharmaceuticals, nanotechnology for drug delivery, and imaging. His work has led to innovations in nanoparticle-based formulations for cancer diagnostics and therapy, including pioneering techniques in hyperthermia and photodynamic therapy. Dr. Amini’s contributions extend to clinical radiology with hands-on expertise in CT and MRI systems. He is fluent in Persian, Kurdish, and English and actively contributes to interdisciplinary projects involving teams of scientists worldwide.

Professional Profile:

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Seyed Mohammad Amini stands as a highly qualified candidate for the “Best Researcher Award” due to his extensive expertise and contributions across several interdisciplinary fields within nanomedicine and biomedical applications. With a Ph.D. and M.Sc. in Medical Nanotechnology from Tehran University of Medical Sciences, he has amassed over 12 years of research and development experience in biopharmaceutical drug development, drug delivery systems, and radiological technology. Dr. Amini’s unique cross-functional research has demonstrated excellence in both theoretical and applied sciences, especially in his innovative work on metal and metal oxide nanostructures, which are pivotal in radiation therapy, photodynamic therapy, and hyperthermia for cancer treatment.

🎓Education:

Dr. Amini completed his Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences (2012-2017), where he specialized in nanoliposomal formulations for controlled cancer drug delivery, supervised by distinguished professors such as Dr. Sharmin Kharrazi and Prof. Jaafari. His Master’s degree (2010-2012) in Medical Nanotechnology from the same university included developing gold nanoparticles for enhanced photodynamic cancer treatment. His academic journey began with a Bachelor’s degree in Radiology (2008-2010) at Tehran University of Medical Sciences, where he gained foundational knowledge in imaging systems and radiology practice. His academic achievements include ranking among the top candidates in national entrance exams for each degree level in Iran.

🏢Work Experience:

With 12 years of extensive R&D experience, Dr. Amini has developed expertise in biopharmaceutical nanotechnology and medical imaging, holding a position as Assistant Professor at the Radiation Biology Research Center, Iran University of Medical Sciences, since 2017. His research spans across drug delivery systems, synthesis of biogenic nanoparticles, and biosensors for targeted drug delivery, along with four years of practical experience as a radiology technologist. Notable projects include developing gold nanoparticles for photodynamic therapy and metal oxide nanoparticles for antimicrobial and theranostic applications. He has contributed significantly to the field of medical nanotechnology with over 50 peer-reviewed publications, patents, and collaborative research grants, proving his capability to lead interdisciplinary teams and communicate effectively across scientific fields.

🏅Awards:

Dr. Amini’s academic excellence is demonstrated by his achievements, such as ranking first in the 2014 Comprehensive Exam for Ph.D. students in Medical Nanotechnology and being awarded the honor of excellence for his M.Sc. thesis by the Iranian Nanotechnology Initiative Council. He ranked second nationally in Iran’s Ph.D. entrance exam in 2012 and has consistently placed highly in national competitions, including the National Nano Competition (7th place, 2012). Dr. Amini’s contributions to medical nanotechnology, specifically in nanoformulations for cancer treatment, have earned him multiple awards and patents for innovative theranostic systems, showcasing his impact in nanomedicine.

🔬Research Focus:

Dr. Amini’s research expertise spans five main areas: nanotechnology for radiotherapy, hyperthermia treatments, photodynamic therapy, green synthesis of nanoparticles, and theranostic applications. He leads pioneering work in developing multifunctional nanoparticles for cancer therapy, including nanostructures for precise thermal and photodynamic treatment. His contributions to biogenic metal nanoparticles for radiosensitization and antimicrobial purposes have furthered the capabilities of non-toxic, plant-based nanomaterial synthesis. Additionally, Dr. Amini has contributed to biosensor innovation by bioconjugating nanostructures with biomolecules for targeted diagnostics and treatments. His research aims to bridge diagnostic and therapeutic applications with nanoparticle-enabled platforms to achieve safer, more effective cancer therapies.

Publication Top Notes:

  1. “Preparation of antimicrobial metallic nanoparticles with bioactive compounds”
    • Citations: 146
  2. “Metal nanoparticles synthesis through natural phenolic acids”
    • Citations: 107
  3. “Evaluation of size, morphology, concentration, and surface effect of gold nanoparticles on X-ray attenuation in computed tomography”
    • Citations: 74
  4. “Safety of nanotechnology in food industries”
    • Citations: 73
  5. “Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks”